Senhwa Biosciences, Inc. (6492.TWO)
TWD 31.6
(-9.97%)
TWD 31.6
(-9.97%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.36 Billion TWD | -17.62% |
| 2022 | 1.65 Billion TWD | -19.73% |
| 2021 | 2.06 Billion TWD | -13.92% |
| 2020 | 2.39 Billion TWD | 178.59% |
| 2019 | 859.74 Million TWD | -30.99% |
| 2018 | 1.24 Billion TWD | -23.37% |
| 2017 | 1.62 Billion TWD | 205.34% |
| 2016 | 532.48 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.22 Billion TWD | -5.46% |
| 2024 Q1 | 1.29 Billion TWD | -5.17% |
| 2023 Q3 | 1.43 Billion TWD | -4.75% |
| 2023 Q4 | 1.36 Billion TWD | -4.66% |
| 2023 FY | 1.36 Billion TWD | -17.62% |
| 2023 Q2 | 1.5 Billion TWD | -3.93% |
| 2023 Q1 | 1.56 Billion TWD | -5.57% |
| 2022 Q3 | 1.75 Billion TWD | -3.48% |
| 2022 Q2 | 1.81 Billion TWD | -5.87% |
| 2022 Q1 | 1.93 Billion TWD | -6.38% |
| 2022 Q4 | 1.65 Billion TWD | -5.64% |
| 2021 Q3 | 2.17 Billion TWD | 0.0% |
| 2021 Q4 | 2.06 Billion TWD | -5.03% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 53.003% |
| Level Biotechnology Inc. | 822.67 Million TWD | -65.72% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -105.098% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -148.444% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 64.988% |
| GlycoNex Incorporation | 1.55 Billion TWD | 12.203% |
| VBI | 452.1 Million TWD | -201.554% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -15.916% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -82.124% |
| Visgeneer Inc. | 397.17 Million TWD | -243.256% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 63.841% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 36.855% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -54.381% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 77.623% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1753.41% |
| Enimmune corporation | 604.82 Million TWD | -125.408% |
| TaiRx, Inc. | 833.74 Million TWD | -63.519% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 55.823% |
| EirGenix Inc. | 11.16 Billion TWD | 87.787% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -137.871% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 20.383% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 62.095% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -29.782% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -352.886% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -415.131% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -209.012% |
| RBC Bioscience Corporation | 753.79 Million TWD | -80.864% |
| BiOptic Inc. | 613.77 Million TWD | -122.123% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 23.351% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -17.557% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -111.419% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 56.11% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -964.711% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -260.325% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -20.24% |
| Neith Corporation | 192.15 Million TWD | -609.503% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -821.581% |
| NaviFUS Corp. | 490.53 Million TWD | -177.927% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -11.227% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 0.003% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -157.647% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -17.388% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 17.687% |
| AP Biosciences Inc | 890.75 Million TWD | -53.053% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 84.012% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -320.589% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -2.226% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 49.712% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 91.126% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -232.311% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -243.537% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 34.326% |
| TCI GENE Inc. | 1.16 Billion TWD | -16.93% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -362.803% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -44.764% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -95.194% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 65.52% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 64.336% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -10.855% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 75.672% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -28.373% |
| Acepodia, Inc. | 6.81 Billion TWD | 80.005% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 64.371% |